Legal Representation
Attorney
Bruce W. Longbottom
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 23, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Jun 23, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Nov 19, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 18, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 13, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 23, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
Classification
International Classes
005